Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Sormani

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Bone Marrow Transplantation|July 9, 2009
Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplantsA Bacigalupo, T Lamparelli, G Milone, et al.
Arthritis and Rheumatism|January 13, 2011
Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A geneM A Pelagatti, A Meini, R Caorsi, et al.
Bone Marrow Transplantation|April 14, 2009
HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor RegistryR Crocchiolo, F Ciceri, K Fleischhauer, et al.
Neuroimage. Clinical|June 18, 2014
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosisR D Newbould, R Nicholas, C L Thomas, et al.
Blood|November 8, 2001
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chainG B Ferrara, A Bacigalupo, T Lamparelli, et al.
Journal of Neurology|February 1, 2023
Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1aH Vrenken, M Battaglini, M L de Vos, et al.
Neurology|June 10, 2010
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypesN De Stefano, A Giorgio, M Battaglini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 3, 2006
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosisE Capello, R Saccardi, A Murialdo, et al.
European Journal of Neurology|June 1, 2018
Clinical activity after fingolimod cessation: disease reactivation or rebound?J Frau, M P Sormani, A Signori, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 16, 2012
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratificationA Laroni, C G Giacomazzi, L Grimaldi, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Bone Marrow Transplantation|July 9, 2009
Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplantsA Bacigalupo, T Lamparelli, G Milone, et al.
Arthritis and Rheumatism|January 13, 2011
Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A geneM A Pelagatti, A Meini, R Caorsi, et al.
Bone Marrow Transplantation|April 14, 2009
HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor RegistryR Crocchiolo, F Ciceri, K Fleischhauer, et al.
Neuroimage. Clinical|June 18, 2014
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosisR D Newbould, R Nicholas, C L Thomas, et al.
Blood|November 8, 2001
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chainG B Ferrara, A Bacigalupo, T Lamparelli, et al.
Journal of Neurology|February 1, 2023
Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1aH Vrenken, M Battaglini, M L de Vos, et al.
Neurology|June 10, 2010
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypesN De Stefano, A Giorgio, M Battaglini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 3, 2006
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosisE Capello, R Saccardi, A Murialdo, et al.
European Journal of Neurology|June 1, 2018
Clinical activity after fingolimod cessation: disease reactivation or rebound?J Frau, M P Sormani, A Signori, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 16, 2012
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratificationA Laroni, C G Giacomazzi, L Grimaldi, et al.
Pageof 11